Tag: Hagens Berman Sobol Shapiro LLP

Insights and updates

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability– Hagens Berman

[ad_1] SAN FRANCISCO, Nov. 25, 2025 /PRNewswire/ –Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series […]